UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications

The Journal of pathology, 2007-03, Vol.211 (4), p.463-470

2007

Link zum Volltext

Verfügbarkeit prüfen

3090 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic or recurrent non-small-cell lung cancer progressing after platinum-based chemotherapy: A phase Ib trial

European journal of cancer (1990), 2015-09, Vol.51, p.S629-S629

2015

Link zum Volltext

Verfügbarkeit prüfen

2630 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with locally advanced or metastatic urothelial carcinoma: A phase Ib trial

European journal of cancer (1990), 2015-09, Vol.51, p.S522-S522

2015

Link zum Volltext

Verfügbarkeit prüfen

2364 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with advanced gastric or gastroesophageal junction cancer: A phase Ib trial

European journal of cancer (1990), 2015-09, Vol.51, p.S457-S457

2015

Link zum Volltext

Verfügbarkeit prüfen

2749 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with recurrent or refractory ovarian cancer: A phase Ib trial reporting safety and clinical activity

European journal of cancer (1990), 2015-09, Vol.51, p.S546-S547

2015

Link zum Volltext

Verfügbarkeit prüfen

Elucidation of the anti-aging effects of ectoine using cdna microarray analysis and signaling pathway evaluation

International journal of cosmetic science, 2010-08, Vol.32 (4), p.319-319

2010

Link zum Volltext

Verfügbarkeit prüfen

9000 ORAL Epidermal Growth Factor Receptor (EGFR) Expression as a Predictive Biomarker of Survival in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving First-Line Therapy With Cetuximab Combined With Chemotherapy in the FLEX Trial

European journal of cancer (1990), 2011, Vol.47, p.S591-S591

2011

Link zum Volltext

Verfügbarkeit prüfen

9002 ORAL Round Robin Test to Evaluate the Reproducibility of a Therapeutically Relevant Immunohistochemical Score for the Categorization of Non-Small Cell Lung Cancer (NSCLC) Into Tumours With High and Low Epidermal Growth Factor Receptor (EGFR) Expression

European journal of cancer (1990), 2011, Vol.47, p.S592-S592

2011

Link zum Volltext

Verfügbarkeit prüfen

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

Bioinformatics, 2002-07, Vol.18 (suppl-1), p.S96-S104

2002

Link zum Volltext

Verfügbarkeit prüfen

Association Between Tumour Lesion Size and Health-Related Quality of Life Outcomes in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

Value in health, 2017-10, Vol.20 (9), p.A455

2017

Link zum Volltext

Verfügbarkeit prüfen

PCN238 - Association Between Tumour Lesion Size and Health-Related Quality of Life Outcomes in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

Value in health, 2017-10, Vol.20 (9), p.A455-A455

2017

Link zum Volltext

Verfügbarkeit prüfen

Avelumab in patients with metastatic adrenocortical carcinoma (mACC): Results from the JAVELIN solid tumor trial

Annals of oncology, 2017-09, Vol.28, p.v324-v324

2017

Link zum Volltext

Verfügbarkeit prüfen

Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization

Analytical biochemistry, 2004-12, Vol.335 (1), p.1-9

2004

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression in Kidney Cancer Is Associated with Cytogenetic Abnormalities, Metastasis Formation, and Patient Survival

Clinical cancer research, 2005-01, Vol.11 (2), p.646-655

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract S1-04: Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: A phase Ib JAVELIN solid tumor trial

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S1-S1-04

2016

Link zum Volltext

Verfügbarkeit prüfen

Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array

Genome research, 2001-11, Vol.11 (11), p.1861

2001

Link zum Volltext

Verfügbarkeit prüfen

3110 Safety and clinical activity of avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with advanced, unresectable mesothelioma: A phase IB trial

European journal of cancer (1990), 2015-09, Vol.51, p.S639-S639

2015

Link zum Volltext

Verfügbarkeit prüfen

Maximum likelihood estimation of mathematical models for genetic development in gastrointestinal stromal tumors

Pathology, research and practice, 2004-01, Vol.200 (4), p.355

2004

Link zum Volltext

Verfügbarkeit prüfen

Cytogenetic and morphologic typing of papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors

Pathology, research and practice, 2004, Vol.200 (4), p.303-303

2004

Link zum Volltext

Verfügbarkeit prüfen

Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: Evidence for a cytogenetic evolution of type 2 from type 1 tumors

Cancer research (Chicago, Ill.), 2003-10, Vol.63 (19), p.6200-6205

2003

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Role of E2F1 and Members of the CDKN2A Network in Gastrointestinal Stromal Tumors

Clinical cancer research, 2005-09, Vol.11 (18), p.6589-6597

2005

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide array analysis of normal and malformed human hearts

Circulation (New York, N.Y.), 2003-05, Vol.107 (19), p.2467-2474

2003

Link zum Volltext

Verfügbarkeit prüfen

Relationship Between EGFR Expression Level, EGFR Mutation Status and the Efficacy of Chemotherapy Plus Cetuximab in Flex Study Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Annals of oncology, 2012-09, Vol.23, p.ix417-ix418

2012

Link zum Volltext

Verfügbarkeit prüfen

Mucin 1-specific active cancer immunotherapy with tecemotide (L-BLP25) in patients with multiple myeloma: An exploratory study

Human vaccines & immunotherapeutics, 2014-11, Vol.10 (11), p.3394-3408

2014

Link zum Volltext

Verfügbarkeit prüfen

Maximum likelihood estimation of oncogenetic tree models

Biostatistics (Oxford, England), 2004-10, Vol.5 (4), p.545-556

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(116)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(122)
Japanisch
(9)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Humans
(37)
Life Sciences & Biomedicine
(37)
Oncology
(27)
Middle Aged
(21)
Aged
(20)
Female
(20)
Adult
(17)
Male
(16)
Tumors
(16)
Hematology, Oncology And Palliative Medicine
(14)
Aged, 80 And Over
(13)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Chemotherapy
(11)
Immunohistochemistry
(10)
Immunotherapy
(10)
Metastasis
(9)
Carcinoma, Renal Cell - Genetics
(8)
Monoclonal Antibodies
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications

3090 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic or recurrent non-small-cell lung cancer progressing after platinum-based chemotherapy: A phase Ib trial

2630 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with locally advanced or metastatic urothelial carcinoma: A phase Ib trial

2364 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with advanced gastric or gastroesophageal junction cancer: A phase Ib trial

2749 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with recurrent or refractory ovarian cancer: A phase Ib trial reporting safety and clinical activity

Elucidation of the anti-aging effects of ectoine using cdna microarray analysis and signaling pathway evaluation

9000 ORAL Epidermal Growth Factor Receptor (EGFR) Expression as a Predictive Biomarker of Survival in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving First-Line Therapy With Cetuximab Combined With Chemotherapy in the FLEX Trial

9002 ORAL Round Robin Test to Evaluate the Reproducibility of a Therapeutically Relevant Immunohistochemical Score for the Categorization of Non-Small Cell Lung Cancer (NSCLC) Into Tumours With High and Low Epidermal Growth Factor Receptor (EGFR) Expression

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

Association Between Tumour Lesion Size and Health-Related Quality of Life Outcomes in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

PCN238 - Association Between Tumour Lesion Size and Health-Related Quality of Life Outcomes in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

Avelumab in patients with metastatic adrenocortical carcinoma (mACC): Results from the JAVELIN solid tumor trial

Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization

Gene Expression in Kidney Cancer Is Associated with Cytogenetic Abnormalities, Metastasis Formation, and Patient Survival

Abstract S1-04: Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: A phase Ib JAVELIN solid tumor trial

Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array

3110 Safety and clinical activity of avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with advanced, unresectable mesothelioma: A phase IB trial

Maximum likelihood estimation of mathematical models for genetic development in gastrointestinal stromal tumors

Cytogenetic and morphologic typing of papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors

Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: Evidence for a cytogenetic evolution of type 2 from type 1 tumors

Prognostic Role of E2F1 and Members of the CDKN2A Network in Gastrointestinal Stromal Tumors

Genome-wide array analysis of normal and malformed human hearts

Relationship Between EGFR Expression Level, EGFR Mutation Status and the Efficacy of Chemotherapy Plus Cetuximab in Flex Study Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Mucin 1-specific active cancer immunotherapy with tecemotide (L-BLP25) in patients with multiple myeloma: An exploratory study

Maximum likelihood estimation of oncogenetic tree models

Suchergebnisse filtern